The investigation of the predictable markers of Sitagliptin effect on glycemic control
Not Applicable
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- JPRN-UMIN000006004
- Lead Sponsor
- Department of Metabolic Medicine, Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who has the impairment of renal function (male Cr > 2.5mg/dl, female Cr 2.0mg/dl or Ccr < 30ml/min) Patient who has nephrotic syndrome Patient who has hypoalbuminemia Patient who has cirrhosis Patient who has malignancy Patient who has pregnant , nurses a baby or may get pregnant Patient who is unsuitable for this study (judged by a doctor)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To elucidate the predictable markers of Sitagliptin effect on glycemic control
- Secondary Outcome Measures
Name Time Method